Yazen “Yaz” Dides is a corporate M&A attorney who specializes at the high-stakes intersection of healthcare transactions, complex regulatory compliance, tax strategy and artificial intelligence. He advises private equity firms, national physician groups, telehealth companies and emerging digital health platforms on legal and regulatory structuring and closing complex transactions. With over $350 million in completed deals, Yaz is recognized for his ability to “de-risk” assets, ensuring that rapid growth strategies align with legacy and developing strict federal and state regulations. . He serves as a strategic partner to investors and innovators, helping them navigate the complex regulatory landscape of the modern healthcare economy.
Yaz is a recognized authority on the “PC-MSO” model. He helps clients build compliant digital health ecosystems where clinical care is delivered by independent physicians (the “Friendly PC”) but efficiently managed by investor-backed technology platforms (the MSO). He regularly advises on:
Yaz’s practice is built on a deep understanding of the financial and operational structures that drive healthcare. He regularly architects creative regulatory structures (e.g., Management Services Organization, Direct-To-Consumer digital platforms; intracompany laboratory ancillary structures) that allow private investors to scale healthcare platforms while remaining compliant under law. Yaz counsels clients on a wide range of regulatory and licensing matters, including Stark Law, Anti-Kickback Statute (AKS), corporate practice of medicine (CPOM), HIPAA, Medicare and Medicaid compliance, AHCA requirements, telehealth and digital health regulations, and FDA/FTC oversight. He works closely with healthcare organizations and investors to align growth strategies with a rapidly changing regulatory environment.
As the industry evolves, Yaz has established a specialized niche in AI Governance and Digital Health. He counsels clients on the legal implications of integrating artificial intelligence into clinical workflows, advising on FDA Software as a Medical Device (SaMD) classifications, algorithmic liability, and data privacy during M&A due diligence and ramp up phases.
Beyond structuring, Yaz advises on the operational risks of DTC healthcare, including asynchronous care models, pharmacy integration, and AI-driven prescribing tools. His background in the Big Four (PwC, EY, Deloitte) and his LL.M. in Taxation allow him to optimize these complex structures for tax efficiency, ensuring that equity rollovers and exit strategies yield maximum returns for investors.
Core Competencies
- Healthcare M&A & Private Equity
- AI Governance & FDA Software Regulation
- MSO Formation & CPOM Compliance
- Tax-Efficient Deal Structuring
Representative Matters:
- Represented national physician practice groups in multimillion-dollar mergers and acquisitions, including sell-side and buy-side transactions.
- Advised private equity funds on the acquisition and consolidation of healthcare platforms, structuring deals for scalability and compliance.
- Guided wellness and telehealth companies through joint ventures, equity rollovers, and recapitalizations.
- Structured and negotiated stock and asset purchase agreements, operating agreements, and shareholder agreements in cross-industry M&A deals.
- Counseled healthcare entities on the regulatory and licensing implications of complex corporate transactions, ensuring compliance while achieving business objectives.
Bar Admissions
- Florida, 2014
Education
- University of Miami School of Law, L.L.M. in Taxation, 2015
- Nova Southeastern University School of Law, J.D., 2014
- Honors: CALI Book award – Business Entities Law
- University of Florida, B.S., Business Administration, 2007